发明授权
US08513202B2 Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate
有权
1-（β-D-吡喃葡萄糖基）-4-甲基-3- [5-（4-氟苯基）-2-噻吩甲基]苯半水合物的结晶形式
![Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate](/docs/US/2013-08-20/US08513202B2/abs.jpg.600x600.jpg)
- 专利标题： Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate
- 专利标题（中）： 1-（β-D-吡喃葡萄糖基）-4-甲基-3- [5-（4-氟苯基）-2-噻吩甲基]苯半水合物的结晶形式
-
申请号： US13103557申请日： 2011-05-09
-
公开(公告)号： US08513202B2公开(公告)日： 2013-08-20
- 发明人: Sumihiro Nomura , Eiji Kawanishi
- 申请人： Sumihiro Nomura , Eiji Kawanishi
- 申请人地址： JP Osaka-Shi
- 专利权人： Mitsubishi Tanabe Pharma Corporation
- 当前专利权人： Mitsubishi Tanabe Pharma Corporation
- 当前专利权人地址： JP Osaka-Shi
- 代理机构： Birch, Stewart, Kolasch & Birch, LLP
- 优先权： JP2006-327019 20061204
- 主分类号： A61K31/7034
- IPC分类号： A61K31/7034 ; C07H7/04
![Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate](/abs-image/US/2013/08/20/US08513202B2/abs.jpg.150x150.jpg)
摘要：
A novel crystal form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate, and having favorable characteristics, is characterized by its x-ray powder diffraction pattern and/or by its infra-red spectrum.
公开/授权文献
信息查询
